Memphasys Prepares for First Australian Sales after Felix Sperm Separation Device Gains TGA Approval
Memphasys (ASX: MEM) gains TGA approval for Felix device, enabling immediate Australian sales and clinic deployments two months ahead of schedule.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results